Fog Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.fogpharma.com
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- CancerColorectal CancerSolid TumorLocally Advanced Solid TumorMetastatic CancerWNT Pathwayβ-cateninBeta-cateninAdenomatous Polyposis ColiAPC
- Interventions
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Parabilis Medicines, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT05919264
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath